$RTRX Travere Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Travere Therapeutics, Inc. for free.
CIK Number: 0001438533
IRS Number: 262383102
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RTRX
Company Address: 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO 92130
Phone number: 646-837-5863
Former name: Desert Gateway, Inc., date of change: 2008-06-25
Former name: Retrophin, Inc., date of change: 2013-02-20
Market Capitalization: $766.34M
Prev close: $20.07
Average Daily Volume: 422,650
Days Low: $19.89
Year Low: $11.60
Year High: $24.57
Travere Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2021 | RTRX | Travere Therapeuti ... | LYONS GARY A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
May 18 2021 | RTRX | Travere Therapeuti ... | LYONS GARY A | Director | Grant | A | 0.00 | 3,000 | 0 | 37,000 | 34 K to 37 K (+8.82 %) |
May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 67,000 | 64 K to 67 K (+4.69 %) |
May 18 2021 | RTRX | Travere Therapeuti ... | Squarer Ron | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
May 18 2021 | RTRX | Travere Therapeuti ... | Squarer Ron | Director | Grant | A | 0.00 | 3,000 | 0 | 14,875 | 11.9 K to 14.9 K (+25.26 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 19.46 | 1,562 | 30,397 | 31,707 | 33.3 K to 31.7 K (-4.70 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 19.14 | 1,563 | 29,916 | 33,269 | 34.8 K to 33.3 K (-4.49 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.46 | 375 | 7,298 | 45,594 | 46 K to 45.6 K (-0.82 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.14 | 375 | 7,178 | 45,969 | 46.3 K to 46 K (-0.81 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 19.46 | 2,000 | 38,920 | 28,223 | 30.2 K to 28.2 K (-6.62 %) |
May 13 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 19.14 | 2,000 | 38,280 | 30,223 | 32.2 K to 30.2 K (-6.21 %) |
Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Option Exercise | M | 16.23 | 10,000 | 162,300 | 140,000 | |
Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Sell | S | 26.23 | 10,000 | 262,300 | 188,940 | 198.9 K to 188.9 K (-5.03 %) |
Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Buy | M | 16.23 | 10,000 | 162,300 | 198,940 | 188.9 K to 198.9 K (+5.29 %) |